Dergiler / International Journal of Computational and Experimental Science and Engineering / 2026 / Cilt: 7 Sayı: 1

Effects of Chelation Therapy on QT Dispersion in Lead Exposed Industry Workers in Turkey

Erdinç Pelit(Didim State Hospital, Aydın. Cardiology Polyclinic)0000-0003-0668-3511
Abdülkadir Çakmak(Amasya University Education and Research Hospital, Department of Cardiology)0000-0001-7427-3368
Arslan Say(AMASYA UNIVERSITY, AMASYA TECHNICAL SCIENCES VOCATIONAL SCHOOL)
Yılmaz Özbay(Amasya University Education and Research Hospital, Department of Cardiology)
Sayfa
35–39
Yayın Tarihi
2021-03-31
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Chelation therapy by Ca-EDTA in lead poisoning could reduce ventricular arrhythmias by homogenizing ventricular repolarization times.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background: Occupational lead poisoning is a common and serious occupational health problem, with workers mainly exposed to lead through inhalation and ingestion.
📊
Temel Bulgular & Veri:Results: A total of 155 male Caucasian workers (mean age = 32 ± 12 years) were evaluated.
💡
Sonuç & Katkı:Conclusion: Chelation therapy by Ca-EDTA in lead poisoning could reduce ventricular arrhythmias by homogenizing ventricular repolarization times.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Lead poisoning · Chelation therapy · QT dispersion

Abstract

Background: Occupational lead poisoning is a common and serious occupational health problem, with workers mainly exposed to lead through inhalation and ingestion. A wide range of studies conducted on lead intoxication and its ECG effects, revealed that QT interval is one of the most important parameters. QT dispersion is a marker of heterogeneity and is frequently encountered in patients with a disparity in ventricular recovery and is implicated as a direct marker of cardiovascular mortality. Methods: Battery, metal mine and car service workers who had been working in the same workplace for at least two years and admitted to Ankara Occupational Diseases Hospital for annual examination and hospitalized with toxic blood lead levels, were enrolled in the study. Patients were given chelation therapy with Ca-EDTA, and ECGs were taken before hospitalization and one week after the chelation therapy. Results: A total of 155 male Caucasian workers (mean age = 32 ± 12 years) were evaluated. The mean blood lead level was 55.3 ± 5.1 μg/dL (min = 45.3 μg/dL max = 70.9 μg/dL). None of the participants had an arrhythmic event or death. QT dispersion before chelation and post-therapy was 38.86±13.24 msec and 35.80±12.32 msec, respectively (p=0.000001). Conclusion: Chelation therapy by Ca-EDTA in lead poisoning could reduce ventricular arrhythmias by homogenizing ventricular repolarization times.

🔖

Bu Makaleye Atıf Yap

Keskin, G., Pelit, E., Çakmak, A., Say, A., Özbay, Y. (2021). Effects of Chelation Therapy on QT Dispersion in Lead Exposed Industry Workers in Turkey. International Journal of Computational and Experimental Science and Engineering, Cilt: 7 Sayı: 1, 35–39. https://ajindex.com/articles/1494089

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. Referans1 Pala, K., Turkkan, A., Gucer, S., Osman, E., & Aytekin, H. (2009). Occupational lead exposure: blood lead levels of apprentices in Bursa, Turkey. Industrial health, 47(1), 97-102. https://doi.org/10.2486/indhealth.47.97
  2. Referans2 Poręba, R., Gać, P., Poręba, M., & Andrzejak, R. (2011). Environmental and occupational exposure to lead as a potential risk factor for cardiovascular disease. Environmental toxicology and pharmacology, 31(2), 267-277. https://doi.org/10.1016/j.etap.2010.12.002
  3. Referans3 Bühler, F. R., Bertel, O., & Kiowski, D. W. (1978). Plasma noradrenaline and adrenaline and β-adrenoreceptor responsiveness in renin subgroups of essential hypertension. Clinical Science and Molecular Medicine, 55(s4), 57s-60s. https://doi.org/10.1042/cs055057s